Anti-tumor Synergistic Effect of a Dual Cancer-Specific Recombinant Adenovirus and Paclitaxel on Breast Cancer

Anti-tumor Synergistic Effect of a Dual Cancer-Specific Recombinant Adenovirus and Paclitaxel on Breast Cancer

This study aimed at investigating the anticancer potential of the recombinant adenovirus Ad-apoptin-hTERTp-E1a (Ad-VT) and its synergistic combination with paclitaxel (PTX) in breast cancer treatment. First, we used the Calcusyn software to analyze the synergy between the Ad-VT and paclitaxel, and t...

Full description

Bibliographic Details
Main Authors: Jing Wang, Yiquan Li, Shanzhi Li, Wei Yao, Xing Liu, Yilong Zhu, Wenjie Li, Liankun Sun, Ningyi Jin, Xiao Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-03-01
Series:Frontiers in Oncology
Subjects:
recombinant adenovirus
paclitaxel
toxicity
synergy
breast cancer
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2020.00244/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2020.00244/full

Similar Items